CBTF: new amine-to-thiol coupling reagent for preparation of antibody conjugates with increased plasma stability.

Amine-to-thiol coupling is the most common route for the preparation of antibody-drug conjugates (ADC). It is usually achieved by using heterobifunctional reagents possessing an activated ester at one end and a maleimide group at the other. However, maleimide-based conjugates were recently revealed to have limited stability in blood circulation, which can compromise therapeutic efficacy of the conjugate. To address this issue, we have developed a heterobifunctional reagent, sodium 4-((4-(cyanoethynyl)benzoyl)oxy)-2,3,5,6-tetrafluorobenzenesulfonate (CBTF), for amine-to-thiol coupling. It comprises a recently described 3-arylpropionitrile (APN) function in replacement of maleimide and allows for the preparation of remarkably stable conjugates. A series of antibody-dye conjugates have been prepared using this reagent and shown superior stability in human blood plasma compared to maleimide-derived conjugates.

[1]  G. W. Anderson,et al.  The Use of Esters of N-Hydroxysuccinimide in Peptide Synthesis , 1964 .

[2]  R. H. Johnson,et al.  Synthesis of N-carbobenzoxyamino acid and peptide pentafluorophenyl esters as intermediates in peptide synthesis. , 1970, The Journal of organic chemistry.

[3]  J. V. Staros,et al.  N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. , 1982, Biochemistry.

[4]  Richard J. K. Taylor,et al.  Tandem Oxidation Processes: The Direct Conversion of Activated Alcohols into Nitriles , 2002 .

[5]  H. Mayr,et al.  Nucleophilicities of amino acids and peptides. , 2007, Organic & biomolecular chemistry.

[6]  Emmanuel Baslé,et al.  Protein chemical modification on endogenous amino acids. , 2010, Chemistry & biology.

[7]  Stephen C Alley,et al.  Antibody-drug conjugates: targeted drug delivery for cancer. , 2010, Current opinion in chemical biology.

[8]  M. Sliwkowski,et al.  Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates , 2012, Nature Biotechnology.

[9]  J. R. Junutula,et al.  Characterization of the drug-to-antibody ratio distribution for antibody-drug conjugates in plasma/serum. , 2013, Bioanalysis.

[10]  Carlos F Barbas,et al.  Rapid, stable, chemoselective labeling of thiols with Julia-Kocieński-like reagents: a serum-stable alternative to maleimide-based protein conjugation. , 2013, Angewandte Chemie.

[11]  J. Reichert,et al.  Antibody-drug conjugates , 2013, mAbs.

[12]  Alain Van Dorsselaer,et al.  Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment. , 2014, Analytical chemistry.

[13]  Jin Y. Jin,et al.  Semi-mechanistic Multiple-Analyte Pharmacokinetic Model for an Antibody-Drug-Conjugate in Cynomolgus Monkeys , 2014, Pharmaceutical Research.

[14]  P. Strop,et al.  World Antibody-Drug Conjugate Summit, October 15–16, 2013, San Francisco, CA , 2013, mAbs.

[15]  C. Barbas,et al.  Improving the Serum Stability of Site-Specific Antibody Conjugates with Sulfone Linkers , 2014, Bioconjugate chemistry.

[16]  L. Friberg,et al.  A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer , 2014, The AAPS Journal.

[17]  P. Senter,et al.  Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates , 2014, Nature Biotechnology.

[18]  Alain Wagner,et al.  Selective irreversible chemical tagging of cysteine with 3-arylpropiolonitriles. , 2014, Bioconjugate chemistry.

[19]  Frank Loganzo,et al.  Mild method for succinimide hydrolysis on ADCs: impact on ADC potency, stability, exposure, and efficacy. , 2014, Bioconjugate chemistry.

[20]  C. Bertozzi,et al.  Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development , 2014, Bioconjugate chemistry.

[21]  Louise Robinson,et al.  Long-term stabilization of maleimide-thiol conjugates. , 2015, Bioconjugate chemistry.